PCV2 - Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany: A Population-Based Modelling Study.
Saved in:
| Title: | PCV2 - Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany: A Population-Based Modelling Study. |
|---|---|
| Authors: | Mueller, M1, Himmler, S1, Basic, E2, Hradetzky, E2 |
| Source: | Value in Health. Oct2017, Vol. 20 Issue 9, pA600-A601. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
